Tango Therapeutics Inc. (TNGX)
2.71
0.09 (3.44%)
At close: Jan 15, 2025, 3:37 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 36.53M | 24.86M | 37.04M | 7.66M | 24.65M |
| Cost of Revenue | 115.20M | 4.03M | 1.97M | 1.63M | 32.27M |
| Gross Profit | -78.67M | 20.83M | 35.08M | 6.03M | -7.63M |
| Operating Income | -114.17M | -111.07M | -58.19M | -52.20M | -15.16M |
| Interest Income | 6.62M | 1.46M | 495.00K | 108.00K | 684.00K |
| Pretax Income | -101.61M | -108.12M | -57.94M | -51.97M | -14.10M |
| Net Income | -101.74M | -108.18M | -58.23M | -51.86M | -14.10M |
| Selling & General & Admin | 35.50M | 30.02M | 17.60M | 9.87M | 7.54M |
| Research & Development | 115.20M | 105.91M | 77.64M | 49.99M | 32.27M |
| Other Expenses | n/a | 2.95M | 247.00K | 120.00K | n/a |
| Operating Expenses | 150.70M | 135.93M | 95.23M | 59.86M | 7.15M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 150.70M | 135.93M | 95.23M | 59.86M | 39.43M |
| Income Tax | 134.00K | 54.00K | 292.00K | -108.00K | n/a |
| Shares Outstanding (Basic) | 94.57M | 87.82M | 62.11M | 31.93M | 8.99M |
| Shares Outstanding (Diluted) | 94.57M | 87.82M | 62.11M | 31.93M | 8.99M |
| EPS (Basic) | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
| EPS (Diluted) | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
| EBITDA | -111.76M | -109.46M | -57.29M | -51.48M | -14.52M |
| Depreciation & Amortization | 2.42M | 4.03M | 1.97M | 1.63M | 643.00K |